Biomedicine company has high hopes for future

2015-09-28T10:14:55-07:00

Earlier this year, Cellular Biomedicine Group Inc, or CBMG, a NASDAQ-listed biomedicine company, announced the acquisition of four novel chimeric antigen receptor T-cells (CAR-T) immuno-oncology technologies and clinical data from ...